Dr. Robert S. Figenshau, MD

Dr. Figenshau practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Figenshau's NPI, 1992723316, was assigned on July 17, 2006. Dr. Figenshau graduated from University Of Minnesota Medical School in 1987. Dr. Figenshau holds Missouri license 103368.

Dr. Figenshau's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Figenshau also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Figenshau's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Figenshau is also affiliated with Missouri Baptist Medical Center. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Figenshau to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Figenshau practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Figenshau's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Figenshau is board certified in urology by the American Board of Urology. Dmand AI has Dr. Figenshau's licenses on file in 2 states: Missouri and Oklahoma.

Dmand AI lists bladder disease, bladder removal, enlarged prostate, erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate surgery among the conditions Dr. Figenshau treats.

CMS data shows 750 Medicare services from Dr. Figenshau across 16 procedure codes in 2024, for 471 Medicare patients. Medicare paid $80,166 for them.

CMS counts 471 Medicare patients who saw Dr. Figenshau in 2024. The largest group is 65 to 74, with 231 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Figenshau's median patient age at 73, with 19% women.

In 2024, Dr. Figenshau wrote 1,008 Medicare Part D claims for 264 patients. 97% of them were for generic drugs. CMS names the drug for 959 of them, across 15 drugs with 11 or more claims each, at $24,971 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Figenshau for performance year 2024, reported as part of a group. Dr. Figenshau accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Figenshau as offering telehealth. CMS counts 16 procedures of prostate resection by Dr. Figenshau, more than 74% of the clinicians it reports for that procedure.

Dmand AI links 160 papers to Dr. Figenshau, published from 2001 to 2025. 2016 was the busiest year, with 8. The most frequent topics are Kidney Neoplasms, Nephrectomy and Laparoscopy. Dr. Figenshau has published most often in J Endourol. Dr. Figenshau's most frequent co-authors are Sam B. Bhayani, MD, Ralph V. Clayman, MD and Eric Hwan Kim, MD.

Dmand AI links Dr. Figenshau to 2 clinical trials. Conditions studied include Kidney Neoplasms, Prostatic Neoplasms and Prostatic Diseases. Washington University School of Medicine sponsors the most, 2.

CMS Open Payments shows 24 general payments to Dr. Figenshau from 11 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 79% of the total. Histosonics, Inc. paid the most, $975.

Dmand AI lists 2 awards for Dr. Figenshau, most recently CMS Stage 1 EHR in 2012.

Dr. Figenshau graduated from University Of Minnesota Medical School in 1987.

Dr. Figenshau is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.